Associated Papers
Genome Instability and Somatic Mutagenesis in Autoimmune Diseases.
Vijayraghavan S et al.
Cancers, 2026
Disease Trajectories and Glucocorticoid Exposure in VEXAS Syndrome Treated with Cytokine-Directed Therapies.
Turturice BA et al.
Annals of the Rheumatic Diseases, 2026
Hypomethylating agents in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS): A systematic review.
Hoff FW et al.
British Journal of Haematology, 2026
VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies.
Groarke EM et al.
Lancet (london, England), 2026
Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.
Fiumara M et al.
Current Opinion in Rheumatology, 2026
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.
Martinez Rodriguez A et al.
British Journal of Haematology, 2026
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden.
Anderson M et al.
Arthritis & Rheumatology (hoboken, N.j.), 2026
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations.
Sakuma M et al.
Leukemia, 2025
Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243.
Nowak D et al.
British Journal of Haematology, 2025
UBA1-depleted neutrophils disrupt immune homeostasis and induce VEXAS-like autoinflammatory disease in mice.
Dong G et al.
The Journal of Clinical Investigation, 2025
Characterizing VEXAS syndrome in women: Findings from an international multicenter study.
Bourguiba R et al.
Journal of Internal Medicine, 2025
Coexistence of VEXAS Syndrome and Chronic Hepatitis B Virus Infection: a Case Report and Literature Review.
Lin K et al.
Clinical Reviews in Allergy & Immunology, 2025
Developing efficient predictive models for the diagnosis of VEXAS syndrome.
Montes D et al.
Seminars in Arthritis and Rheumatism, 2025
VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms.
Kaul A et al.
The Lancet. Rheumatology, 2025
Novel Insights into the Clinical Features, Genetic Spectrum and Clonal Evolution of Patients Carrying NLRP3 Mosaicism.
Bonet N et al.
Journal of Clinical Immunology, 2025
Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score.
von Bornemann Fløe L et al.
Journal of Clinical Immunology, 2025
Emerging insights into mosaic errors of immunity.
Roosens W et al.
Trends in Immunology, 2025
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.
Wadsworth PA et al.
American Journal of Clinical Pathology, 2025
From diagnostic uncertainty to targeted therapy: a case-based review of VEXAS syndrome.
Rana G et al.
Rheumatology International, 2025
VEXAS syndrome caused by a UBA1 mutation is complicated by recurrent infections leading to hemophagocytic lymphohistiocytosis.
Tang Y et al.
Genes & Diseases, 2025
Prevalence and outcome of VEXAS syndrome in unrelated hematopoietic cell transplantation for bone marrow failure.
Zaimoku Y et al.
Clinical and Experimental Medicine, 2025
Ocular Features of VEXAS Syndrome: A Systematic Review and Meta-analysis.
Quigley C et al.
American Journal of Ophthalmology, 2025
VEXAS syndrome with eosinophilia and pathologically mimicking histiocytosis: a case report.
Murai Y et al.
Modern Rheumatology Case Reports, 2025
Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.
Fiumara M et al.
Expert Review of Hematology, 2025
Kidney involvement in VEXAS syndrome: insights from a rare case of secondary amyloidosis and systematic review of renal biopsy-confirmed reports.
Ştefan G et al.
Clinical Rheumatology, 2025
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.
Kirino Y et al.
Rheumatology (oxford, England), 2025
VEXAS syndrome through a rheumatologist's lens: insights from a Spanish national cohort.
García-Escudero P et al.
Rheumatology (oxford, England), 2025
Therapeutic Challenges in the Management of VEXAS Syndrome: A Case Report.
Kelly G et al.
The Australasian Journal of Dermatology, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.
Molteni R et al.
Nature Medicine, 2025
Rapid Screening and Monitoring of UBA1 Mutations in VEXAS Syndrome.
Martín Castillo I et al.
The Journal of Molecular Diagnostics : Jmd, 2025
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder - A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape.
Singh A et al.
Journal of Autoimmunity, 2025
In depth transcriptomic profiling defines a landscape of dysfunctional immune responses in patients with VEXAS syndrome.
Mizumaki H et al.
Nature Communications, 2025
Altered IgG4 serum levels in VEXAS syndrome - a retrospective monocentric cohort study.
Saur SJ et al.
Rheumatology International, 2025
VEXAS syndrome with p.Met41Leu UBA1 gene mutation misdiagnosed as tumid lupus: A series of 3 cases.
Mizes A et al.
Jaad Case Reports, 2025
[VEXAS- NEWLY REPORTED SYNDROME WITH OCULAR MANIFESTATIONS: CASE REPORT].
Abumanhal M et al.
Harefuah, 2025
Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment.
Johansen MM et al.
Rheumatology (oxford, England), 2025
Neurological manifestations in patients with VEXAS syndrome.
Bert-Marcaz C et al.
Journal of Neurology, 2025
Novel use of Siltuximab in a patient with VEXAS Syndrome.
Cáceres-Nazario B et al.
Annals of Hematology, 2025
VEXAS Syndrome: Histiocytoid Cells With Feathery Cytoplasm as a Clue to the Diagnosis.
Ko CJ et al.
Journal of Cutaneous Pathology, 2025
Concurrent inhibited erythropoiesis in a case of VEXAS syndrome.
Xing L et al.
Annals of Hematology, 2025
Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, and Somatic (VEXAS) Syndrome: A Diagnostic and Therapeutic Conundrum.
Miranda S et al.
Cureus, 2025
Utilizing C. elegans Spermatogenesis and Fertilization Mutants as a Model for Human Disease.
Perez SM et al.
Journal of Developmental Biology, 2025
A Japanese case of VEXAS syndrome after COVID-19 vaccination: Comparison with previously reported cases.
Miyagi Y et al.
Modern Rheumatology Case Reports, 2025
VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation.
Kötter I et al.
Current Opinion in Rheumatology, 2025
Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.
Gurnari C et al.
British Journal of Haematology, 2025